1-3 of 3
Richard Hong Hui Quek, MD
Close
Sort by
Journal Articles

A Case of Two Young Brothers with Natural-Killer/T-Cell Lymphoma

Tiffany Tang, MD, Maarja-Liisa Nairismagi, PhD, Alvin Yu Jin Ng, PhD, Byrappa Venkatesh, Joanne Ngeow, MD, Shao-Tzu Li, Yurike Laurensia, BSc, Jing Quan Lim, PhD, Sanjanaa Nagarajan, MSc, Burton Chia, Jing Tan, PhD, Yeow Tee Goh, MD, Miriam Tao, MD, Richard Hong Hui Quek, MD, Mohamad Farid, MD, Soon Thye Lim, MD, Choon Kiat Ong
Journal: Blood
Blood (2016) 128 (22): 5293.
https://doi.org/10.1182/blood.V128.22.5293.5293
Published: 2016
Journal Articles

Role of Consolidation High Dose Chemotherapy (HDC) with Autologous Stem Cell Transplant (ASCT) Support in Patients with Peripheral T-Cell Lymphoma Who Achieved Complete Remission (CR1) Following First Line Induction Chemotherapy

Lay Poh Khoo, BSc, Tiffany Tang, MD, Suk Teng Chin, BSc, Jeslin Ha, BSc, Colin Phipps, MBBS, MRCP, FRCPath, Yuh Shan Lee, MBBS, MRCP, FRCPath, Mohamad Farid, MD, Kevin Tay, MD, Miriam Tao, MD, Richard Hong Hui Quek, MD, Soon Thye Lim, MD
Journal: Blood
Blood (2016) 128 (22): 4640.
https://doi.org/10.1182/blood.V128.22.4640.4640
Published: 2016
Journal Articles

A Phase II Study of Bortezomib-GIFOX (Gemcitabine, Ifosfamide, Oxaliplatin) in Patients with Newly Diagnosed Natural-Killer/T-Cell Lymphoma

Tiffany Tang, MD, Kevin Tay, MD, Miriam Tao, MD, Richard Hong Hui Quek, MD, Mohamad Farid, MD, Soon Thye Lim, MD
Journal: Blood
Blood (2016) 128 (22): 5353.
https://doi.org/10.1182/blood.V128.22.5353.5353
Published: 2016